BCL2 and metabolic dysfunction-associated steatotic liver disease: Using the same biomarkers as in our study, Panasiuk and colleagues [28] showed that the intensification of inflammation in NAFLD may also impact on biomarker expression in human hepatocytes with the induction of pro-apoptotic protein p53 and the inhibition of anti-apoptotic Bcl-2.